TCRX Financials
Tscan Therapeutics Inc - Financial statements & key metrics
Stock Price
$0.61
Market Cap
$62.11M
P/E Ratio
-0.5
EPS
$-1.14
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$2.82M
Gross Profit
-
Operating Income
-
Net Income
$-127.50M
EPS (Diluted)
$-1.14
Balance Sheet Highlights
Total Assets
$371.12M
Total Liabilities
$130.15M
Shareholders Equity
-
Cash & Equivalents
$178.69M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-110.82M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Net Margin
-4527.7%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is TCRX revenue?
TCRX's most recent quarterly revenue was $2.82M. Annual revenue can be calculated by summing the four most recent quarters.
Is TCRX profitable?
TCRX reported a loss of $127.50M in the most recent quarter. The net profit margin is -4527.7%.
What is TCRX market cap?
TCRX has a market capitalization of $62.11M, making it a small-cap stock.
Does TCRX have debt?
View TCRX's balance sheet for debt information.
What is TCRX cash flow?
Cash flow data is available in the full financial statements.